Regarding adiponectin, it can promote the β-oxidation of fatty acids, glucose utilization, and the suppression of fatty acid synthesis, and its levels are decreased in patients with MAFLD, thus playing a role in the development of insulin resistance [56,154,155,156]. The gene discussed is ADIPOQ; the disease is Insulin resistance.